Centralized institutional review board (CIRB) for minimal risk registry linkage studies- FY24
Active Purchase Order Awarded Last action
- Contract number
- 75N91024P00604
- Awardee
-
Biomedical Research Alliance Of New York LLC UEI L1K7UFDEG5N5
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $81,520
Award facts
- Opportunity
-
- Centralized Institutional Review Board (CIRB) for Minimal Risk Registry Linkage Studies Pre-Solicitation · 75N91024Q00068 · Posted Mar 22, 2024
- Contract value 23% obligated
-
- $81,519.75 Current, with exercised options
- $349,564.75 Potential, with all options
- Completion date 77% complete
- Current and potential, with all options
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Set-aside
- No set-aside
- Competition
- Not Competed under SAP · 1 offer Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- New Hyde Park, NY 11042, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Exercise an Option | $24,312 | |
| Exercise an Option | $25,467 | |
| Original award | $31,741 |
About this award
The National Cancer Institute awarded a purchase order to Biomedical Research Alliance Of New York LLC for centralized institutional review board services supporting minimal risk registry linkage studies, with a ceiling value of $349,564.75 and an award date of August 7, 2024.
Performance will occur in New Hyde Park, New York. The order covers establishment and operation of a centralized IRB to intake, process, and review multi-state minimal risk registry linkage studies, with a target of at least 50 reviews per year during the base period. The contractor must establish reliance agreements with central cancer registries and maintain AAHRPP accreditation. The ultimate completion date is July 6, 2027, reflecting a base period of twelve months plus two twelve-month option periods. The underlying solicitation, posted March 22, 2024, contemplated a Time and Materials contract type; this award is firm fixed-price.
Quick answers
Who was awarded contract 75N91024P00604?
75N91024P00604 was awarded to Biomedical Research Alliance Of New York LLC by National Cancer Institute (National Institutes of Health) on August 7, 2024.
How much is contract 75N91024P00604 worth?
The government has obligated $81,520 on 75N91024P00604. Its potential value, with all options, is $349,565.
Was contract 75N91024P00604 competed?
The extent of competition for 75N91024P00604 was not competed under sap. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award